Abstract
A male neonate with hyperbilirubinaemia and progressing anaemia due to rhesus (c+E) incompatibility received high dose intravenous gammaglobulin (ivIgG) therapy at 13 days of age. Clinical response to therapy was confirmed by a rapid decrease in serum bilirubin level, and with the prevention of a further decline of the haemoglobin level. No side-effects were noted. High dose ivIgG therapy could be an alternative to (exchange) blood transfusion in case of some haemolytic diseases of newborn.
Similar content being viewed by others
Abbreviations
- ivIgG:
-
high-dose intravenous gammaglobulin
- HND:
-
haemolytic disease of newborn
- Rh:
-
rhesus
References
Berkman SA, Lee ML, Gale RP (1990) Clinical use of intravenous immunoglobulins. Ann Int Med 112:278–292
Berlin G, Selbing A, Ryden G (1985) Rhesus haemolytic disease treated with high-dose intravenous immunoglobulin. Lancet I:1153
Camara CDL, Arrieta R, Gonzalez A, Iglesias E, Omenaka F (1988) High-dose intravenous immunoglobulin as the sole prenatal treatment for severe Rh immunization. N Engl J Med 318: 519–520
Derycke M, Dreyfus M, Ropert JC, Tchernia G (1985) Intravenous immunoglobulin for neonatal isoimmune thrombocytopenia. Arch Dis Child 60:667–669
Hara T, Mizuno Y, Kawano M, Ueki Y, Ueda K (1987) Treatment of immune hemolytic anemia with gammaglobulin. J Pediatr 110:817–818
Oda H, Honda A, Sugita K, Nakamura A, Nakajima H (1985) High-dose intravenous intact IgG infusion in refractory autoimmune hemolytic anemia (Evans syndrome). J Pediatr 107:744–746
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kubo, S., Ariga, T., Tsuneta, H. et al. Can high-dose immunoglobulin therapy be indicated in neonatal rhesus haemolysis?. Eur J Pediatr 150, 507–508 (1991). https://doi.org/10.1007/BF01958434
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01958434